Month: April 2013

Agents and preservatives both influence trabeculectomy outcome

SAN FRANCISCO — While preservatives used in topical agents contribute to exacerbating ocular surface disease that may affect the success of trabeculectomy, the agents themselves may also be contributors, according to a speaker here.Preservatives do have desirable attributes, Douglas J. Rhee, MD, said at Glaucoma Day preceding the American Society of Cataract and Refractive Surgery meeting.

Presbyopic LASIK best for young patients with accommodation

SAN FRANCISCO — Despite a few visual downsides, presbyopic LASIK is an alternative to multifocal IOLs and corneal inlays, particularly in relatively young presbyopes with some accommodation, a speaker said here.During Cornea Day preceding the American Society of Cataract and Refractive Surgery meeting, Gustavo Tamayo, MD, discussed the multifocality that is generated with presbyopic LASIK.

Innovation in ophthalmology pushes forward

SAN FRANCISCO — The future of innovation in ophthalmology is promising, with more forward movement than drag, according to a speaker here. “The tailwinds are stronger than the headwinds,” William J. Link, PhD, managing director of Versant Ventures, told colleagues interested in supporting innovation in the ophthalmic space at the Ophthalmology Innovation Summit.

FDA focus on more efficient processing yields faster decisions

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval process. Recognizing this criticism, and following implementation of the Medical Devices User Fee and Modernization Act of 2002 and subsequent internal reevaluations and reorganizations, the FDA approval process for innovative technologies has been gaining speed since 2010.“We believe the U.S. is and should remain the leading innovation leader,” Malvina B. Eydelman, MD, director of the FDA Division of Ophthalmic and Ear, Nose and Throat Devices, (Read more...)

Near-infrared and Short-wavelength Autofluorescence in Resolved Central Serous Chorioretinopathy: Association With Outer Retinal Layer Abnormalities – Corrected Proof

Purpose: To evaluate the correlation between changes in fundus autofluorescence (AF) measured using 2 different sources (near-infrared fundus autofluorescence from melanin and short-wavelength fundus autofluorescence from lipofuscin) with changes in spectral-domain optical coherence tomography (SD OCT) and fluorescein angiography in resolved central serous chorioretinopathy (CSC).Design: Retrospective, observational case study.Methods: A total of 91 eyes from 86 patients with a history of resolved CSC and abnormal AF imaging findings were included. In addition to AF, patients were assessed by means of SD OCT and fluorescein angiography. Outer retinal layer alterations in OCT images and abnormalities in fluorescein angiography were analyzed and (Read more...)

Umbilical cord blood serum promotes endothelial healing in severe dry eye

Heterologous umbilical cord blood serum-based eye drops may enable healing of diseased corneal epithelium and reduce symptoms in patients with severe dry eye disease, according to a study.The study included 33 eyes of 17 patients with graft-versus-host disease and 26 eyes of 13 patients with Sjögren’s syndrome. Patients’ mean ages were 38.8 years in the graft-versus-host disease group and 59.6 years in the Sjögren’s syndrome group. All patients received sterile cord blood serum eye drops daily for 1 month.